phenformin has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boros, LG; Collins, TQ; D'Agostino, DP; Hitendra, P; Meuillet, EJ; Somlyai, G | 1 |
| Baquero, P; Dunn, K; Gottlieb, E; Helgason, GV; Holyoake, TL; Kuntz, EM; Michie, AM; Tardito, S | 1 |
1 review(s) available for phenformin and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma.
Topics: Atorvastatin; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Metformin; Phenformin | 2017 |
1 other study(ies) available for phenformin and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells.
Topics: Animals; Anti-Bacterial Agents; Blotting, Western; Cell Survival; Chromatography, Liquid; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Imatinib Mesylate; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mass Spectrometry; Metabolomics; Mice; Mice, Inbred NOD; Minocycline; Mitochondria; Neoplastic Stem Cells; Oxidative Phosphorylation; Phenformin; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline; Tumor Cells, Cultured; Tumor Stem Cell Assay; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |